Rasio utang jangka cendhak marang ekuitas: Protagenic Therapeutics, Inc. (PTIX)
The price action visualization for Protagenic Therapeutics (PTIX) on the GURU.Markets platform shows the metric at 0.00, while the business leverages executive expertise in the CNS field and strict control over R&D costs. Protagenic Therapeutics (PTIX) is currently launching primary clinical trials for new psychiatric disorder treatments to attract investment, which will culminate in the release of safe peptide-based antidepressants.
Protagenic - rincian analitis lan metrik utama (PTIX)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Protagenic Therapeutics|PTIX - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Protagenic Therapeutics|PTIX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Protagenic Therapeutics Inc.|PTIX - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Protagenic Therapeutics|Rasio cepet protagenic.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:PTIX Protagenic Therapeutics, Inc.
Developing synthetic peptides to combat depression within strict ESG standards, Protagenic Therapeutics (PTIX) maintains financial stability through liability control, where the current value of 0.00 reflects the ratio of short-term loans to net equity, allowing investors to assess liquidity risk and the company's solvency by tracking the dynamics of debt under one year relative to equity.
Pesaing Protagenic Therapeutics (PTIX)
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|Utang jangka cendhak marang ekuitas Catalyst Pharmaceuticals|denalitherapeutics.com - Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Harmony Biosciences Holdings, Inc. (HRMY)|BHVN (Biohaven Ltd) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Amylyx AMLX|Trevi Corp (TRVI) - Kewajiban jangka cendhak marang modal|PRAX: Rasio utang jangka cendhak marang ekuitas|anavex.com - Rasio silihan jangka cendhak marang modal|CBLL: Utang jangka cendhak marang modal|Prothena Biosciences (PRTA) - Utang jangka cendhak marang modal|ALEC (Alector Inc.) - Utang jangka cendhak marang modal|ANNX - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal OMER|NGNE - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas AC Immune SA ACIU|VYGR: Rasio utang jangka cendhak marang modal|Neumora Therapeutics Inc - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Scilex Holding Company, Inc. SCLX|TVGN: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Alpha Cognition Inc.|Rasio utang jangka cendhak marang ekuitas CGTX|IKT: Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas SAVA (Cassava)|Rasio silihan jangka cendhak marang modal ASRT|Utang jangka cendhak marang modal COYA (Coya Therapeutics)|Rasio tanggungan utang jangka cendhak marang modal VTGN|Ovid Rx - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Acumen Pharmaceuticals Inc.|CervoMed Inc (CRVO) - Utang jangka cendhak marang ekuitas|Alterity Therapeutics Limited - Rasio tanggungan utang jangka cendhak marang modal|CLNN (Clene Inc) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal PepGen Corp|Utang jangka cendhak marang ekuitas Jupiter Neurosciences (JUNS)|RLMD: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal ANVS (Annovis Bio Corp)|Grace Therapeutics Inc (GRCE) - Kewajiban jangka cendhak marang modal|AIFF: Rasio utang jangka cendhak marang ekuitas|KLTO - Utang jangka cendhak marang modal|NRSN (neurosense-tx.com) - Rasio utang jangka cendhak marang ekuitas|RVPH: Rasio silihan jangka cendhak marang modal|MTVA (MetaVia Inc.) - Utang jangka cendhak marang modal|NeurAxis Inc (NRXS) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal HSDT|Rasio utang jangka cendhak marang ekuitas passagebio.com PASG|Utang jangka cendhak marang ekuitas Neuphoria Therapeutics NEUP|Koefisien utang jangka cendhak marang modal Minerva Neurosciences Inc (NERV)|ATHA - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas ADXN|ALZN (alzamend.com) - Rasio utang jangka cendhak marang ekuitas|CYCN: Rasio silihan jangka cendhak marang modal|KTTA (Pasithea Therapeutics Corp) - Utang jangka cendhak marang modal|Cortigent Medical (CRGT) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ATXI (Avenue Therapeutics, Inc)|BrainStorm Cell Therapeutics Inc. - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cara Therapeutics, Inc. CARA|CHRO: Rasio utang jangka cendhak marang modal|Eliem - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Intra-Cellular Therapies|LBPH (Longboard Pharma) - Rasio utang jangka cendhak marang ekuitas|Marinus Pharma (MRNS) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NKGen Biotech, Inc.|NRBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Sage Therapeutics (SAGE)|SNPX - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Trevena, Inc TRVN|VIGL (Vigil Neuroscience Inc.) - Kewajiban jangka cendhak marang ekuitas|WENA - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal CERE (cerevel.com)